BD announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments. The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology, profiled on the cover of the journal Science in 2022, and BD SpectralFX Technology – bringing to market breakthrough innovations in real-time imaging and spectral flow cytometry. The three- and four-laser additions to the BD FACSDiscover S8 Cell Sorter family complement the five-laser instrument launched last year and provide scientists greater access, options, and flexibility to incorporate real-time imaging and spectral cell sorting technology in their labs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Citi opens ‘positive catalyst watch’ on Becton Dickinson into earnings
- AngioDynamics settles litigation with Becton Dickinson
- Upcoming Deadline to Share in Becton, Dickinson and Company (BDX) Class Action Settlement
- 5 Best Healthcare Stocks to Buy in March 2024, According to Analysts
- Becton Dickinson further increases U.S. syringe production